Evento de educación virtual para pacientes con cáncer de ovario

Learn about ovarian cancer treatment and research at virtual patient education event

Join Providence Cancer Institute of Oregon and Ovarian Cancer Alliance of Oregon and SW Washington for a free, virtual patient education event for ovarian cancer patients and their caregivers.

Christopher Darus, M.D., MS, gynecologic oncologist and medical director of Providence Gynecologic Oncology Program, will give an update on the latest developments in ovarian cancer diagnoses, treatments, research and clinical trials.

Virtual event details

June 29, 2022
7:00 p. m. to 8:15 p. m.

Register here

About Dr. Christopher Darus

Dr. Christopher Darus joined Providence Cancer Institute in October 2020 as medical director of Providence Gynecologic Oncology Program. He previously was director of gynecologic cancer research at Maine Medical Center in Portland, Maine.

Dr. Darus graduated from Wright State University School of Medicine in 2000 and completed his residency in Obstetrics and Gynecology at University of Colorado Health Sciences Center in 2004. Following his residency, he completed a fellowship in Gynecologic Oncology at the University of Virginia Health System in 2007. This rigorous training prepared Dr. Darus to offer advanced surgical and medical treatment techniques to his patients.

Dr. Darus has an acute understanding of the impact of a gynecologic cancer diagnosis and treatment on his patients and their families. He emphasizes the importance of treating the whole patient while utilizing the skills and strengths of the multidisciplinary team of providers at Providence Cancer Institute. His clinical interests include minimally invasive surgery, clinical trials and cancer genomics.

Dr. Darus is an avid cook and enjoys scuba diving and underwater photography. He lives in Portland with his wife and children.

Exceptional gynecologic cancer care

The Providence Gynecologic Oncology Program provides specialized care for women with suspected or known gynecologic malignancies and complex precancerous conditions. We offer care at two locations: Robert W. Franz Cancer Center at Providence Portland Medical Center and Providence St. Vincent Medical Center.

Through the program, patients have access to advanced treatments, such as robotic surgery, immunotherapy, and the latest research and clinical trials. Patients also have the convenience of receiving all their care in a single location. Learn more.

Related resources

Clinical trials: Leading breakthroughs in cancer research

Clinical trial aims to help premenopausal women at risk for ovarian cancer

Gynecologic oncology care now available at Providence Cancer Institute

For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.
New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.
A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.
Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.
Powered by Translations.com GlobalLink OneLink SoftwarePowered By OneLink